Qiu Xiao-Xia, Li Zheng
Department of Research and Education, Shulan (Hangzhou) Hospital, Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310022, Zhejiang Province, China.
Jiangsu Engineering Research Center of Cardiovascular Drugs Targeting Endothelial Cells, College of Health Sciences, School of Life Sciences, Jiangsu Normal University, Xuzhou 221000, Jiangsu Province, China.
World J Hepatol. 2024 Oct 27;16(10):1213-1215. doi: 10.4254/wjh.v16.i10.1213.
Xiaoyao San (XYS) is a classic Chinese medicine prescription. It is traditionally used to relieve syndrome of "liver stagnation and spleen deficiency", a common syndrome type in traditional Chinese medicine, through soothing liver, tonifying spleen, and nourishing blood. Correspondingly, XYS has long application in the treatment of depression, dyspepsia and liver diseases. Given the rising of cutting-edge researches on XYS, there's a significant need to diligently uncover the bioactive constituents and action mechanisms of XYS for treating non-alcoholic fatty liver disease accordingly.
逍遥散（XYS）是一种经典的中药方剂。传统上，它通过疏肝、健脾、养血来缓解中医常见证型“肝郁脾虚”。相应地，逍遥散在抑郁症、消化不良和肝脏疾病的治疗中有着长期应用。鉴于对逍遥散前沿研究的不断增加，迫切需要相应地深入揭示逍遥散治疗非酒精性脂肪性肝病的生物活性成分及作用机制。
